Our Story

 TissueGUARD GmbH was founded in 2019 as a spin-off from the Leibniz Institute of Polymer Research Dresden (IPF), Germany, to explore innovative materials and biotechnology solutions for medical devices and regenerative therapies. 

Today, TissueGUARD is an FDA-registered medical device company specializing in proprietary ophthalmic devices and accessories. The company also develops and offers advanced hydrogel materials and biotechnology solutions for tissue engineering, cell therapies, and organoid therapeutics.